The budget 24\/25 <\/a>and spend information pages<\/a> within the DiiS can be used to identify potential savings opportunities and to track progress against the financial indicators.<\/a><\/span><\/p>\n<\/div><\/div><\/div><\/div><\/div> Audit<\/span>\u00a0CGM\u00a0<\/span>prescribing<\/span>\u00a0using the SystmOne searches provided <\/span>to ensure it\u00a0<\/span>is in keeping with the updated <\/span>commissioning<\/span> statement<\/span><\/a><\/span> on the Dorset formulary: if not,\u00a0refer the prescription\u00a0request\u00a0back to initiating prescribing team via advice and guidance or provide the patient with the guidance in the resource tab.<\/span><\/span><\/span><\/p>\n<\/div><\/div><\/div> CGM technologies have been appraised by NICE and funded by NHS Dorset based on its updated published policy<\/a>. Prescribing outside of this policy\u00a0is not commissioned and people will need to self-fund or meet the requirements of an individual funding request.<\/p>\n<\/div><\/div><\/div> Review the people identified in the provided search in SystmOne and complete the automated SystmOne CGM template (version 3) to record where any people qualify for CGM but are incorrectly coded.<\/p>\n Refer\u00a0inappropriate new CGM prescription requests\u00a0using \u2018declined prescribing request form\u2019 to ensure CGM devices are prescribed in line with NG28, the updated Dorset CGM policy<\/a> and commissioning statement <\/a>at their next diabetes review.<\/p>\n For existing CGM prescription which no longer meet the eligibility criteria within the updated Dorset CGM policy<\/a> and commissioning statement<\/a>, either refer the prescription request back to initiating prescribing team via advice and guidance or provide the patient with the guidance in the resource tab.<\/p>\n<\/div><\/div><\/div> Dorset Formulary CGM Sub Section \u2013 includes Commissioning Statement and other supporting documents<\/a><\/p>\n SystmOne searches: Dorset SystmOne GPs\/PQS Finance 24 25\/F6 CGM outside commissioning policy<\/span>.<\/span><\/span><\/span><\/p>\n Accessing the Continuous Glucose Monitoring (CGM) SystmOne Protocol<\/p>\n Automated SystmOne Template \u2018CGM NHS Dorset Version 3\u2019.<\/span><\/p>\n Template letter to hospital to decline prescribing<\/span><\/a><\/p>\n Patient Letter<\/a><\/p>\n General practice messaging about change in access to CGM<\/a><\/p>\n For queries for complex questions, send to\u00a0<\/span>medicine.question@nhsdorset.nhs.uk<\/span><\/a><\/p>\n<\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div> The GLP-1 RA shortage is becoming more pressing and in Dorset we currently prescribe 30% more of these agents than other systems in our region. Tackling this shortage in a structured way will not only reduce the impact on patients who continue to need these treatments but will also help meet CCLIP targets for 23\/24.<\/p>\n Further information is available on the Dorset Formulary.<\/a><\/p>\n<\/div> Glucagon-like peptide \u2013 1 agonists (GLP-1)<\/p><\/h3><\/div> A Dorset audit of general practice GLP-1 prescribing shows that NG28 is not routinely followed at initiation or at 6 monthly review.<\/p>\n This work will support management of the national shortage of GLP-1 agents, expected to last into 2024.<\/p>\n As a system we aim to save over \u00a3400,000 by adopting these changes.<\/p>\n<\/div><\/div><\/div> Work with diabetes leads in practices and PCNs to identify people in CCLIP searches published in\u00a0<\/span>SystmOne<\/span>\u00a0to ensure a GLP-1 medicines are prescribed in line with NG28 at their next diabetes review.<\/span><\/span>\u00a0<\/span><\/p>\n<\/div><\/div><\/div> Cease prescribing of insulin pen needles with a cost greater than \u00a35 per 100 needles and replace with a suitable formulary option.<\/span>\u00a0<\/span><\/p>\n Only issue safety pen needles to patients who require healthcare professional assistance to administer insulin.<\/span>\u00a0<\/span><\/p>\n<\/div><\/div><\/div>Continuous Glucose Monitoring (CGM)<\/h2><\/div>
<\/i><\/i><\/span>What are you asking me to do?<\/span><\/a><\/h4><\/div>
<\/i><\/i><\/span>Why are you asking me to do this?<\/span><\/a><\/h4><\/div>
<\/i><\/i><\/span>How do I do it?<\/span><\/a><\/h4><\/div>
<\/i><\/i><\/span>What resources\/support is provided to help me deliver this?<\/span><\/a><\/h4><\/div>
GLP-1 Agonists<\/h2><\/div>
\n
<\/i><\/i><\/span>What are you asking me to do?<\/span><\/a><\/h4><\/div>
\n
<\/i><\/i><\/span>Why are you asking me to do this?<\/span><\/a><\/h4><\/div>
<\/i><\/i><\/span>How do I do it?<\/span><\/a><\/h4><\/div>
<\/i><\/i><\/span>What resources\/support is provided to help me deliver this?<\/span><\/a><\/h4><\/div>
\n
Insulin pen needles (>\u00a35)<\/h2><\/div>
<\/i><\/i><\/span>What are you asking me to do?<\/span><\/a><\/h4><\/div>